MedTrace Logo

Indocyanine Green Tissue Perfusion Monitoring

NCT02978560 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2024-11-27

No results posted yet for this study

Summary

The aim of this project is to demonstrate that fluorescence-mediated photoplethysmography (FM-PPG) is capable of routinely acquiring the tissue perfusion data sufficient to detect and monitor skin tissue perfusion anomalies.

Conditions

  • Regional Blood Flow
  • Wound Heal

Interventions

DIAGNOSTIC_TEST

fluorescence-mediated photoplethysmography

Indocyanine green dye (ICG) will be injected intravenously as a sterile solution at a dose of 0.5 mg/kg, and then imaging of skin will be done with a fluorescence camera. The ICG-angiogram sequence will consist of 1.5 x 2.0-cm field-of-view ICG fluorescence images acquired at the rate of approximately 30/sec during a period of about 15 seconds. Following acquisition of the initial transit angiogram sequence, several additional 15-second-long image sequences will be acquired during the next half-hour, but without any additional injections.

Sponsors & Collaborators

  • Baltimore Medical & Surgical Associates PA

    collaborator UNKNOWN

  • University of Maryland, Baltimore

    lead OTHER

Principal Investigators

  • Stephen R Thom, MD, PhD · University of Maryland, Baltimore

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-03-05
Primary Completion
2018-06-28
Completion
2018-07-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02978560 on ClinicalTrials.gov